Reclaim Your Health with GLP-1 Injections: A New Path to Weight Loss
Begin a weight loss journey that’s uniquely yours. Our personalized programs combine cutting-edge medical treatments with tailored wellness strategies, empowering you to achieve sustainable results on your terms.
Semaglutide
Semaglutide, a GLP-1 receptor agonist, is approved for chronic weight management in adults with obesity or overweight conditions.
Tirzepatide
Tirzepatide, is a dual GIP and GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight conditions.
Lose Up To
Clinical Studies
Participants using semaglutide achieved an average weight loss of approximately 15%, with some individuals losing up to 20% of their body weight.
*Clients utilizing compounded GLP-1 injections through Weight Loss by Tulin have reported an average weight loss of 11.7 pounds within the first month.*